Chapter 11: Red Blood Cell Pathology & Anemias

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive.

Today we are opening up a case file that every medical student and really any inquisitive biological learner has to crack eventually.

Oh, absolutely.

It's a story of supply chains, mechanical failures,

genetic typos, and microscopic warfare.

We are talking about the red blood cell.

It is deceptive, isn't it?

You look at a drop of blood and it just seems like this uniform red fluid.

Yeah, just red.

But when you put that slide under the microscope, specifically looking at Chapter 11 of the USMLE Step One Lecture Notes for Pathology, you realize it is a chaotic, bustling ecosystem.

Exactly.

And that is our source material today, Chapter 11 from the 2017 edition.

And just to be clear for everyone listening, we are sticking strictly to the high yield pathology principles laid out right here in this text.

We aren't going to speculate on experimental gene therapies from 2024 or anything like that.

We are going to master the fundamental logic of disease as it's taught to doctors.

Which is the best foundation you can have, really.

Pathology is not about memorizing a giant list of symptoms.

It is about understanding the mechanism.

The why.

The why.

If you understand why a cell is shaped the way it is, you don't have to memorize the disease associated with it.

The shape tells you the story.

That is our mission today.

We are going to treat this chapter like a detective manual.

The red blood cell is our victim, our witness, and sometimes the perpetrator.

We're going to move through the visual evidence, the math of the bone marrow, and then categorize the suspects, the anemias by size.

The three big categories.

Small, normal, and large.

It is a classic approach, the morphological approach.

It works.

So let's start right at the top of the chapter.

Section one, red blood cell morphology.

The text calls this the visual language.

Before we even talk about diseases, we have to define what we're looking at.

We need the vocabulary.

Exactly.

We have two big terms here, anisocytosis and poikilocytosis.

Right.

And these are the descriptors of chaos.

In a healthy person, red blood cells are pretty uniform, like a stack of identical dinner plates.

They all look the same.

Biconcave discs.

Perfect biconcave discs.

But when things go wrong, you get variation.

Anisocytosis refers to variation in size.

OK, size.

The prefix aniso means not equal.

So you have some giant cells, some tiny cells, all mixed together.

And poikilocytosis.

That refers to variation in shape.

So the cells are twisted.

They're spiked.

They're bitten or they're fragmented.

So if I'm a pathologist and I see a report that says anisopoikilocytosis.

You know immediately that something is wrong.

Either the bone marrow is under serious stress or the cells are being destroyed out in the circulation of the big red flag.

OK, so let's walk through the rogue's gallery of shapes that are listed in the text.

I want to paint a picture for you, the listener.

Imagine you're looking down the microscope.

The first thing you might see is a cell that isn't a disc.

It's a sphere.

A perfect little red ball with no central dimple.

The spherocyte.

This is a crucial finding.

And to understand the spherocyte, you have to remember what a normal RBC is.

That biconcave disc.

Right, like a donut without the hole punched all the way through.

That shape is brilliant because it gives it extra surface area.

It can bend and fold and squeeze through the tiniest capillaries in your body.

So what happens in a spherocyte?

Why does it lose that shape?

The cell has lost membrane.

It's like taking a partially deflated balloon and squeezing it tight in your fist.

It just rounds up.

It becomes dense.

Becomes round, dense, and inflexible.

The text highlights that spherocytes have a decreased membrane to volume ratio.

It's lost its coat.

And where do we see this?

What's the story it's telling us?

Two main scenarios.

One is genetic, hereditary spherocytosis.

In that case, the protein tethers holding the membrane skeleton together are broken, so bits of membrane just flake off.

OK, so a structural problem.

Exactly.

The other is immune mediated.

Autoimmune hemolytic anemia.

In that case, the body's own antibodies are basically taking little bites out of the membrane.

And with each bite, the cell loses some surface area and it shrinks and tightens until it pops into a sphere.

OK, so spherocyte means tight membrane, a loss of surface area.

What about the opposite?

The target cell.

Visually, this one looks exactly like a bull's eye.

You have a dark center of hemoglobin, a pale white ring around it, and then a dark outer ring.

So is the mechanism here the inverse of the spherocyte?

Precisely.

In a target cell, you have too much membrane for the amount of hemoglobin inside.

It's like wearing a suit that is three sizes too big.

And the fabric bunches up.

The membrane flops over and bunches up in the center, creating that central red dot.

The text lists a few associations here.

I always remember the mnemonic HALT.

That's a good one.

HBC disease, esplenia, liver disease, and thalassemia.

Liver disease is a big one.

The liver is in charge of lipids.

When it fails, the RBC membrane picks up extra cholesterol and it expands, gets floppy.

And that causes the target shape.

And thalassemia is the other classic cause because you aren't making enough hemoglobin to fill the suit.

The bag is too big for the groceries, so to speak.

That's a great analogy.

Okay, moving on, we have acanthocytes.

These look nasty,

spiky, irregular projections.

They're often called spur cells and the spikes are irregular and sharp.

The text links this to a pretty rare condition called a beta -lipoproteinemia.

Which is a disorder of lipid metabolism.

Right, the membrane literally has the wrong chemical composition.

It has the wrong fats in it and that causes it to spike out like that.

Now, how do we contrast that with acanthocytes or burr cells?

Because they also sound spiky.

They are spiky, but it's a different kind of spike.

Burr cells have uniform, smaller, more wavy projections like the surface of a sea urchin.

They're more regular.

Okay.

Now, you have to be careful with these.

Often, burr cells are just an artifact.

Something went wrong when the technician dried the slide.

The cell dehydrated weirdly.

But if they're real.

If they're real, they're a classic sign of uremia, which is kidney failure.

The toxins that build up in the blood alter the membrane shape.

Okay, so one is a lipid problem, one is a toxin problem.

Now we get to a real crime scene shape.

The schistocyte, also known as the helmet cell.

This is one of the most urgent findings in all of hematology.

A schistocyte is a fragment.

It's not a whole cell.

It looks like a jagged piece of shrapnel or.

A little soldier helmet.

A soldier's helmet, exactly.

And the mechanism here is just pure violence.

Pure mechanical violence.

We call it microangiopathic hemolytic anemia, or MAHA.

MAHA.

Imagine the small blood vessels are spanned by strands of fibrin -like razor wire or a clothesline strung across a highway.

The red blood cell tries to rush past at high speed and just gets sliced in half.

That is a visceral image.

The text specifically references figures 11 to two and 12 to two to show this.

And it's seen in things like DIC, TTP, HUS.

Exactly, conditions where tiny clots are forming all over the microvasculature.

If you see schistocytes on a smear, you aren't dealing with a simple nutrition problem.

You're dealing with a mechanical shredding problem happening inside the patient's vessels right now.

That's a true emergency.

Absolutely.

Okay, let's look at two more shapes that tell a story about the spleen.

The bite cell and the teardrop cell.

Let's start with the bite cell.

It looks exactly like a cookie that someone took a semi -circular bite out of.

It's a very descriptive name.

So what's taking the bite?

The spleen.

The spleen acts as the quality control inspector of the blood.

It checks every red cell that passes through.

If it finds a solid chunk of something bad inside the cell.

Inclusion.

An inclusion, right.

Usually it's denatured hemoglobin, which we call a Heinz body.

The splenic macrophage physically grabs the cell, bites out that Heinz body, seals the membrane back up and releases the damaged cell back into circulation.

And that is the hallmark of G6PD deficiency.

The absolute hallmark.

Okay, and the teardrop cell or dacricite.

This is a sadder story.

This happens when the bone marrow, the home of the red blood cells, is full of scar tissue, a condition called myelofibrosis.

The marrow is fibrosed.

Right, so the red blood cell is trying to leave the marrow to get into the circulation,

but it has to squeeze through these tight fibrotic bands.

As it pushes through, it gets pinched and stretched out into a teardrop shape.

So it's literally crying because the home it's leaving is destroyed.

That's a very poetic and a very accurate way to remember myelofibrosis.

That really sticks with you.

Finally, for shakes, let's talk about the stack of coins, Rouleau.

This is an aggregation problem.

Red blood cells normally have a negative charge on their surface that helps them repel each other.

They stay separate.

Like magnets pushing each other away.

Exactly.

But if you have very high levels of protein in the blood, specifically immunoglobulins, antibodies, that charge gets masked.

And they get sticky.

They get sticky.

The cells stick together face to face like a roll of quarters.

This is the classic, classic sign of multiple myeloma, a cancer of plasma cells that produce massive amounts of antibody.

Okay, we've looked at the shape of the cell.

Now let's look inside the cell, the inclusions.

The text lists five key things you can find inside an RBC that shouldn't be there.

Let's run through the differential diagnosis.

First up, how old jolly bodies.

These are dark purple dots you see inside the red cell.

They are remnants of nuclear material, a little bit of leftover DNA.

But red cells don't have a nucleus.

Exactly.

Normally when a red blood cell is born in the marrow, it kicks out its nucleus.

If a little piece gets left behind, the spleen usually plucks it out on the first pass.

So if I see a how old jolly body, it means the spleen fell asleep on the job.

Or the spleen is gone.

The presence of how old jolly bodies is a biological signpost for a splenia, a patient with no spleen or what we call functional hyposplenia.

Meaning a spleen that's there but doesn't work.

Right, like we see in sickle cell disease after years of damage.

Okay, next inclusion,

basophilic stippling.

It sounds like lots of tiny blue dots scattered throughout the cytoplasm.

That's exactly what it is.

And those dots are RNA.

Specifically, they're ribosomes that haven't been properly degraded.

What does that tell us?

It's a bit nonspecific.

It can happen anytime the bone marrow is rushing production and is a little sloppy.

But for the purposes of the board exams and what's in the text, the strong association is lead poisoning.

Why lead?

Lead inhibits an enzyme that's responsible for breaking down RNA.

So the ribosomes just persist and you see them as this blue stippling.

Got it, Pachenheimer bodies.

Those are iron granules.

You see these in conditions where iron is overloaded but not being used properly like Cideroblastic anemia.

Which brings us to ring Cideroblasts.

Right, now this is a bone marrow finding, not something you see in the peripheral blood.

You have to do a bone marrow biopsy and stain it with Prussian blue, which stains iron.

And what do you see?

You see a ring of blue dots encircling the nucleus of the developing red cell.

That blue is iron that has gotten trapped inside the mitochondria.

It can't be incorporated into heme.

And that is the definition of Cideroblastic anemia.

It is the pathognomonic finding.

And we already mentioned Heinz bodies,

the precipitation of uniglobin seen in G6PD deficiency.

Which is what the macrophage bites out.

To create the bite cell, it's all connected.

It really is, the morphology tells the whole story.

Okay, section two.

We are moving from the visual to the logical.

The chapter calls this the logic of anemia.

The text defines anemia simply as a reduction in total circulating red cell mass.

And we need to pause on the physiology here because this is something that confuses a lot of people early on.

In anemia, the patient is tired, they're pale, maybe short of breath on exertion.

But if you put a pulse oximeter on their finger, what does it say?

It says 98%, it looks totally normal.

Exactly, and if you were to do an arterial blood gas, the Po2, the pressure of oxygen physically dissolved in the blood, is also normal.

This is the bridge to physiology note in the book.

Why is that?

Why are those numbers normal when the patient feels so bad?

Because the lungs are working perfectly fine, the oxygen is crossing from the air into the blood, just as it should.

The problem isn't the quality of the blood, it's the quantity of the carriers.

The hemoglobin.

Right, the oxygen saturation, the SO2, is the percentage of hemoglobin seeds that are filled with oxygen.

In anemia, you might only have half the normal amount of hemoglobin, but every single molecule you do have is 100 % saturated.

So the oxygen content, the total amount of oxygen being carried is low, even though the saturation percentage is normal.

Correct, the total delivery of oxygen to the tissues plummets, and that's what causes the fatigue, the weakness, and the angina.

Okay, that's a fantastic clarification.

Now, when the oxygen delivery drops, the kidney senses it, and it screams for help.

It releases EPO, or erythropoietin, to stimulate the marrow.

It's the make more red cells signal.

And this brings us to the math portion of our deep dive, the reticulocyte count.

This is critical, absolutely critical for working up an anemia.

The reticulocyte is the baby red blood cell.

It's just been released from the marrow.

It still has some RNA, so it looks a little blue on the stain.

We call it polychromatia.

So if you're anemic, your bone marrow should be pumping these out like crazy to compensate.

It should be an overdrive.

So we look at the lab report.

It gives us a raw reticulocyte percentage.

Say it's 3%, normal is roughly 1%.

So the student thinks, great, three is bigger than one, the marrow is working.

And that student would be wrong.

You cannot look at the raw percentage.

You absolutely must correct it for the degree of anemia.

Okay, walk us through the math.

Let's use an example.

We have a patient with a hematocrit of 20.

Normal is around 45.

The raw red account from the lab is 5%.

Okay, so think about it this way.

If you have very few red blood cells overall, because you are anemic, a 5 % red account is 5 % of a very small number.

It's an illusion.

It's artificially inflated.

We need to standardize it to what it would be in a normal blood volume.

So how do we do that?

The formula in the book is the correct account equals the reticulocyte percentage times the patient's hematocrit divided by 45.

Okay, so for our guy, 5 % times 20 divided by 45.

20 divided by 45 is roughly 0 .44.

Right, so five times 0 .44 gives us a corrected count of about 2 .2%.

And the cutoff is usually around 3%.

In the text, they say a good response is 3%, and a poor response is 2%.

So 2 .2 % is borderline, but it's not a robust response.

So what does that tell us?

It suggests the marrow is failing to respond adequately.

This is likely a production problem, not a destruction problem.

If the corrected count was, say, 7%, you'd know the marrow's working great and the cells are being destroyed somewhere else.

But wait, the text throws in one more wrench, the reticulocyte production index, or RPI.

Ah, yes.

This is for when the anemia is really, really severe.

The marrow gets so desperate it pushes out reticulocytes too early.

They're premature.

Very premature.

We call them shift cells.

And they take two days to mature in the blood instead of the usual one day.

So they hang around longer, which artificially inflates the count again.

Exactly, you're double counting them in a way.

So if you see significant polychromasia on the smear, which tells you shift cells are present, you have to take your corrected count and divide it by two.

So in our example, that 2 .2 % becomes 1 .1%.

And 1 .1 % is a terrible response.

That tells you for sure that this patient has a production failure.

It's not hemolysis.

I love that.

You have to punish the math because the cells are lingering.

It's so logical.

It is.

Once you understand the why,

the formulas make perfect sense.

Okay, so we've checked the marrow response.

Now we classify the anemia using the MCV roadmap.

This is the bread and butter of step one hematology.

It's the three lanes of traffic.

The first question you always ask is what is the MCV?

The mean corpuscular volume.

How big are the cells?

How big are the cells on average?

So lane one, microcytic.

The MCV is less than 80.

The cells are too small.

Lane two, normacytic.

The MCV is between 80 and 100.

The cells are normal size.

And lane three, macrocytic.

The MCV is greater than 100.

The cells are huge.

Let's drive down lane one, microcytic anemias.

The small cells.

The basic principle here, the unifying theme, is that the cell is small because it doesn't have enough stuff to fill it up.

And what is the stuff?

The stuff is hemoglobin.

And hemoglobin, if you remember, is made of two parts, heme and globin.

And heme is made of iron and protoporphyrin.

And that simple breakdown gives you the entire differential diagnosis for microcytic anemia.

It's beautiful.

Break it down for us.

Number one, a problem with iron.

That could be a lack of iron, which is iron deficiency.

Or it could be an inability to use the iron, which is anemia of chronic disease.

Number two, a problem with globin.

You're not making enough globin chains.

That's thalassemia.

And number three.

A problem with protoporphyrin.

You can't make the porphyrin ring to hold the iron, that's sideroblastic anemia.

And you can also throw lead poisoning in there because lead messes up heme synthesis.

That's a fantastic framework.

Let's start with the most common one in the world, iron deficiency.

The text breaks this down into stages, which I find really helpful.

I like to think of it as a bank account analogy.

It fits perfectly.

Stage one is depleting your savings account.

This is your storage iron.

Your ferritin goes down.

If you did a bone marrow biopsy, you'd see the iron stores are gone.

But you feel fine.

You feel fine.

Your checking account, the iron circulating in the blood serum, is still normal.

You are not anemic yet.

Okay, stage two.

Now the savings are gone and you're starting to drain the checking account.

Your serum iron level drops and the body, realizing it's broke, starts raising the credit limit.

The TIBC, the total iron binding capacity, goes up.

What is TIBC exactly?

It's a measure of how many open seats there are on the transferrin protein, which is the bus that carries iron around.

When you're iron deficient, the body makes more of these empty buses hoping to catch any scrap of iron floating by.

So serum iron is low, but TIBC is high.

But the red cells are still being made normally at this point.

For a while, yes.

This can be a stage of normacytic iron deficiency.

The marrow is just keeping up.

And then stage three, bankruptcy.

The marrow can no longer make normal cells.

It runs out of iron completely.

It starts churning out small, pale, empty cells.

Microcytic hypochromic anemia.

This is when the patient finally walks into the clinic feeling tired and weak.

You may be eating dirt.

Yes, pica, or chewing on ice, which is called pagophagia.

The text also mentions the classic physical signs.

Coelanica, which are spoon -shaped nails.

And the Plummer -Vincent triad.

I always remember this one.

It's a memorable one.

The triad is anemia, esophageal webs, which cause dysphagia or difficulty swallowing, and a beefy red tongue, or glossitis.

If you see a woman with trouble swallowing and spoon nails, check her iron levels.

Definitely.

Now, we have to distinguish iron deficiency from its evil twin, anemia of chronic disease, or AOCD.

This is where interpreting the iron panel in table 11 to one becomes the battleground.

So important.

In both conditions, the serum iron is low.

In both conditions, the patient is anemic, so how do we tell them apart?

You have to look at the storage mechanism.

In iron deficiency, the body is truly empty, the warehouse is bare, ferritin is low.

In anemia of chronic disease, the body is full of iron, but it's hiding it.

The warehouse is full, but the doors are locked.

Why would the body hide its own iron?

This is the Hepsodin story.

It's an evolutionary defense mechanism.

Think about it.

If you have a chronic infection or inflammation, like rheumatoid arthritis or tuberculosis,

what do those bacteria or inflammatory processes need to thrive?

They need iron.

They need iron.

So your body has a wartime protocol.

The inflammation, specifically a cytokine called interleukin 6, stimulates the liver to produce a hormone called Hepsodin.

And what does Hepsodin do?

Hepsodin is the jailer.

It does two critical things.

First, it goes to the gut and locks the door, preventing you from absorbing any new iron from your diet.

Second, and more importantly, it goes to the macrophages, which are the cells that recycle iron from old red blood cells, and it locks their doors from the inside.

The iron is trapped inside the macrophages.

It cannot get out and get to the bone marrow.

So the bone marrow is starving for iron, even though the macrophages are stuffed with it.

Exactly.

So when you look at that lab panel, ferritin is H -I -N -G -H because storage is full, and T -I -B -C is L -W because the body isn't trying to capture more iron, it's trying to hide the iron it has.

That high ferritin and low T -I -B -C is the fingerprint of anemia of chronic disease.

It's the absolute key.

Empty warehouse versus locked warehouse.

That's such a crucial distinction.

Okay, let's talk about the globin problem, thalassemia.

So thalassemia is a quantitative defect.

The genetic instructions for the globin chains are fine, but the printer is jammed.

You just aren't making enough of either the alpha or the beta chains.

Let's start with the alpha thalassemia.

We have four genes for alpha chains, two from each parent.

Right, and the severity of the disease depends entirely on how many of those four genes you delete.

So one deletion.

You're a silent carrier, you're fine.

Two deletions is alpha thalassemia trait.

You might have a mild microcytic anemia, but you're generally asymptomatic.

Three deletions.

Now you have a serious problem, that's HBH disease.

And four deletions is hydroxvitalis, which is incompatible with life.

The fetus dies in utero.

I wanna focus on that two deletion scenario.

The text differentiates between cis and trans deletions.

Why does that genetic detail matter so much?

It matters for the next generation.

It's all about genetic counseling.

In the cis deletion, which is common in Asian populations, both deletions on the same chromosome.

So one chromosome from a parent is empty and the other is normal.

Right, and in the trans deletion?

Common in African populations, there is one deletion on each of the two chromosomes.

Each chromosome is missing one gene.

So why is cis worse for the offspring?

Because if two parents both have the cis deletion, there is a 25 % chance that their child will inherit two of those empty chromosomes.

One from mom, one from dad.

And two empty chromosomes means four deleted genes.

And that's hydroxvitalis, it's a lethal combination.

With the transmutation, because the deletions are on separate chromosomes, the parents will almost always pass on at least one working gene to their child.

So hydroxvitalis is extremely rare.

That's a fascinating and really important clinical point.

Now what happens in that three deletion scenario, HBH disease?

If you're only making a tiny amount of alpha chains,

the beta chains, which are normally being produced, are supposed to pair up with alpha.

They get lonely, they have no partners.

So what do they do?

They form tetramers of pure beta chains.

We call this hemoglobin H or B4 -tentillars.

And these PD4 -torter tetramers are unstable.

They precipitate in the red cell, they damage the membrane and they cause hemolysis.

Okay, now let's switch to beta thalassemia.

This involves the two beta genes.

Right, beta thalassemia minor, where you have one mutated gene is usually asymptomatic.

You have a mild microcytic anemia.

But beta thalassemia major, also known as Cooley anemia, is devastating.

You have no functional beta chains.

And the text makes a key point that this doesn't show up at birth.

No, because at birth, the baby is running on fetal hemoglobin or HBF.

And HBF is made of two alpha chains and two gamma chains.

It doesn't use beta chains.

Oh, so the problem is hidden.

It's hidden.

But around six months of age, the body switches from gamma chain production to beta chain production.

Suddenly the baby needs beta chains and they just aren't there.

The anemia becomes severe very quickly.

The clinical picture here is intense.

The book describes chipmunk faces and a crew cut skull on x -ray.

It sounds almost cartoonish, but it reflects a desperate physiology.

The anemia is so profoundly severe that the kidney is just screaming EPO continuously.

Make more cells.

Make more cells.

So the bone marrow tries to expand to meet the demand.

It expands into the bones of the skull, into the cheekbones.

It causes these skeletal deformities because the marrow is literally pushing the bone outwards to make room for more factories.

The factories are producing junk.

It's called ineffective erythropoiesis.

The cells are so defective that most of them die right there in the marrow before they ever get out.

Wow.

Okay, before we leave microcytic, quickly explain cyroblastic anemia.

It's listed under microcytic, but you said the iron is high, which seems contradictory.

It is.

This is a defect in the third component of him, protoporphyrin.

You have plenty of iron.

You have plenty of globin, but you can't make the porphyrin ring that the iron sits in.

So the iron has nowhere to go.

It has nowhere to go.

The iron arrives at the mitochondria, which is where the final step of heme synthesis happens.

It finds no porphyrin ring to bind to, and it just gets stuck there.

It piles up.

And that creates the ring cyroblast.

Visually, that creates the ring cyroblast, the iron -laden mitochondria encircling the nucleus.

And because the iron isn't being used, the serum iron is high, the ferritin is high.

It looks just like iron overload, but the patient is paradoxically anemic.

Okay, shifting gears, lane two.

Normacytic anemias.

The cells are a normal size, MCV is 8 ,100,

but there just aren't enough of them.

And this is where that reticulocyte count we talked about becomes your guide.

You have to split this category in two.

Right, if the redic count is low.

It's a marrow failure, a production problem.

The classic example is a plastic anemia.

And if the redic count is high.

The marrow is working just fine.

The problem is destruction.

The cells are being destroyed out in the periphery.

That's hemolysis.

And hemolysis itself is divided into two crime scenes.

Intravascular, or IV, where the murder happens right inside the blood vessel.

And extravascular, or EV, where the murder happens in the spleen or the liver.

How do we tell them apart clinically?

What are the clues?

In intravascular hemolysis, the red cell bursts open right in the bloodstream.

Hemoglobin spills out everywhere.

It immediately binds to a scavenger protein called haptoglobin.

So haptoglobin levels would go down.

They drop to zero, because it's all used up trying to clean up the mess.

Then, the excess haemoglobin that's left over spills into the urine.

You get haemogloinuria, which is dark, red -brown urine, and haemocynuria, which is iron in the urine sediment cells.

And in extravascular hemolysis.

The macrophage in the spleen just eats the whole cell.

So haemoglobin doesn't spill into the plasma.

You don't get haemoglobin inuria.

So what do you get instead?

You get the byproducts of haemoglobin breakdown.

The macrophage converts the heme into unconjugated bilirubin.

This builds up in the blood, leading to jaundice and an increased risk of pigment gallstones.

And because the spleen is working overtime, eating all these cells, you get splenomegaly.

That's a very clear distinction.

Let's look at the specific diseases.

Sickle cell anemia.

This is the prototype for normocytic hemolytic anemia.

Walk us through the molecular defect.

It's a single point mutation, a single letter change in the DNA code for the beta -globin chain.

This results in a single amino acid substitution.

At position number six, a normal glutamic acid is replaced by a valine.

And that one tiny change causes all this devastation.

Why?

Because you're switching from a hydrophilic, a water -loving amino acid, to a hydrophobic, a water -hating one.

And this creates a sticky patch on the haemoglobin molecule.

A sticky patch.

When the haemoglobin is fully oxygenated, the molecule's in a relaxed shape and it kinda hides that hydrophobic spot.

But when the oxygen leaves, in the deoxygenated state, the molecule changes shape.

That hydrophobic valine pops out.

And wants to hide from the water.

It wants to hide from the water and the blood, so it snaps into a hydrophobic pocket on a neighboring haemoglobin molecule.

They link up, then another links up.

They polymerize, forming a long, rigid, crystal -like chain.

This physically distorts the cell into that classic crescent or sickle shape.

And once it sickles, it gets stuck.

That's the vaso -occlusion.

It's no longer flexible.

It can't squeeze through capillaries.

It logs up the small vessels.

This is what causes the intense pain crises and the tissue infarction or death.

The spleen takes a major hit here, you mentioned.

The spleen is a particular target.

It's basically a dense meshwork of tiny vessels.

The sickle cells plug it up repeatedly, over and over again, starting in infancy.

The spleen infarcs and dies, bit by bit.

So by the time a patient is an adult.

The spleen is just a shrunken, fibrotic nub.

We call it autosplenectomy.

The body has effectively removed its own spleen.

And this brings back the howl -jolly bodies.

Exactly, the spleen is gone, so the nuclear remnants persist.

But much more importantly, the patient loses their primary defense against encapsulated bacteria, like streptococcus pneumonia and haemophilus influenza.

Infection is a major cause of death.

Okay, let's talk about proxysmal,

nocturnal haemoglobinuria, or PNH.

The mechanism here is complex, and the name itself is a mouthful.

It suggests it happens at night.

Why?

This is a fascinating physiological loop.

It's really elegant once you break it down into steps.

Let's do that.

Step one, the defect.

The patient has an acquired mutation in a gene called PIGA.

This gene makes the anchor, called a GPI anchor, that attaches certain proteins to the cell surface.

Specifically, it attaches two very important proteins, CD55 and CD59.

And what do CD55 and CD59 do?

They are the don't eat me signs for the complement system.

Our blood is full of these complement proteins that are always on patrol, ready to attack and blow up bacteria.

CD55 and CD59 tell the complement system, hey, I'm a human cell, I'm one of you, don't blow me up.

PNH cells lack these protective signs.

They're missing their shield.

Okay, so they're vulnerable.

Step two, sleep.

When you go to sleep, your respiratory drive naturally decreases.

You breathe a little bit shallower and a little bit slower.

Because of this, you retain a little bit more CO2 than when you're awake.

CO2 in the blood combines with water to form carbonic acid.

So every single person becomes slightly acidotic at night.

It's mild, but it's real.

Set three, activation.

The complement system happens to be activated by acidosis as one of its triggers.

So at night it wakes up, it looks around, it sees the red blood cells.

The normal cells have their shield up.

There's CD55 and CD59.

The PNH cells have no shield.

So they get attacked.

The complement attacks the PNH cells and Co -oleolysis them.

It blows them up inside the vessel.

It's an intravascular hemolysis.

Which brings us to step four, morning.

The patient wakes up, goes to the bathroom, and their first morning urine is dark red or cola colored.

That's the hemoglobinuria from all the cells that pop during the night.

Paroxysmal, nocturnal, hemoglobinuria.

That is a brilliant explanation of that chain reaction.

And because this is a stem cell defect, it's not just the red cells that are affected.

Right, correct.

Platelets and white cells also lack the anchor.

So you get pancetopenia, low counts of all cell lines.

And strangely, the most common cause of death in PNH isn't the anemia, it's venous thrombosis.

Clots that form in unusual places like the veins of the liver.

Let's touch on G6PD deficiency quickly.

We already mentioned the bite cells in Heinz bodies.

This is an X -linked enzyme defect.

G6PD or glucose -6 -phosphate dehydrogenase is essential for protecting the cell from oxidative stress.

How does it do that?

It helps regenerate a molecule called glutathione, which is the cell's main antioxidant.

Without G6PD, you can't regenerate glutathione.

So if the cell is exposed to an oxidant from fava beans, sulfa drugs, certain antimalarials, or even a bad infection, the hemoglobin gets oxidized and destroyed.

And it precipitates into a Heinz body.

Which the spleen then bites out, creating a bite cell, and the rest of the damaged cell is destroyed.

It's a classic example of extravascular hemolysis.

And what about hereditary serocytosis?

We discussed the shape, the spherocyte, which is due to a defect in the membrane's skeleton proteins like anchoring or spectrum.

The key lab finding here that the text highlights is the osmotic fragility test.

What's that?

Because the cell is already a tight little sphere, it has no room to swell.

If you put a normal red cell in a hypotonic solution, a watery solution, water rushes in, and it can swell up quite a bit before it pops.

The spherocyte has no spare capacity.

It pops almost immediately.

It's osmotically fragile.

And the treatment?

Splenectomy.

You can't fix the defective shape of the cell, but you can remove the organ that is programmed to eat them.

It cures the anemia, but not the spherocytosis.

We must contrast this with autoimmune hemolytic anemia, AIHA.

Both can have spherocytes.

How do we distinguish them?

The Coombs test, also called the direct anti -globulin test.

This is the key.

How does it work?

In hereditary spherocytosis, the problem is the cytoskeleton.

There are no antibodies involved.

The Coombs test is negative.

In AIHA, the problem is antibodies coating the red cell, marking it for destruction.

The Coombs test detects these antibodies, so it will be positive.

The text breaks AIHA down into warm type, which is caused by IgG antibodies, and cold type caused by IgM.

And warm is associated with things like lupus, CLL, or drugs like penicillin.

Exactly.

And cold is classically associated with infections like mycoplasma pneumonia or mononucleosis.

Okay, section five, macrocytic anemias, lane three, the big cells.

MCV is over 100.

And the text immediately divides this category into megaloblastic and non -megaloblastic.

That's the first branch point.

What does megaloblastic actually mean?

It's a strange word.

It refers to a very specific type of growth failure, nuclear cytoplasmic asynchrony.

Untag that for us.

Imagine the developing red cell is a factory.

The cytoplasm, which is the shop floor, is growing normally.

It's making proteins, it's making RNA, it's getting bigger.

But the nucleus, which is management, is stuck.

It cannot synthesize DNA fast enough to give the order to divide.

So the two parts are out of sync.

Completely out of sync.

The factory floor keeps getting bigger and bigger, waiting for the command to split into two new factories.

But the command never comes.

You end up with a giant cell, what we call a macroovalocyte.

And this doesn't just affect the red cells?

No, it affects all rapidly dividing cells, especially in the bone marrow.

The neutrophils get huge and their nuclei become hypersegmented.

What does that look like?

A normal neutrophil has a nucleus with three or four lobes.

In megaloblastic anemia, you see neutrophils with five, six, seven, even eight lobes.

Finding a hypersegmented neutrophil is the visual hallmark of this condition.

And the two main causes are vitamin B12 deficiency and folate deficiency.

They both look the same on a blood smear.

How do we possibly parse them out?

You have to look at the symptoms and the metabolic byproducts.

Clinically, this is one of the most important distinctions in medicine.

B12 deficiency causes neurological symptoms.

Folate deficiency does not.

What are those neurological symptoms?

It's a condition called subacute combined degeneration of the spinal cord.

The myelin sheaths in the spinal cord get destroyed, specifically the dorsal columns and the lateral cordical spinal tracks.

So what does the patient experience?

They lose vibration sense and proprioception, their sense of where their limbs are in space,

and they get spasticity and weakness from the motor track damage.

Why the nerve damage in B12 but not folate?

It comes down to a specific biochemical reaction.

B12 is needed as a cofactor to convert a molecule called methylmalonic acid, or MMA, into succinyl CoA.

If you lack B12, MMA piles up.

And high levels of MMA are toxic to myelin.

So that's the key.

We can measure that.

We can.

So in the lab workup, B12 deficiency will give you a high homocysteine level and a high methylmalonic acid level.

And folate.

Folate is also involved in homocysteine metabolism, so you'll have a high homocysteine.

But it's not involved with MMA, so you'll have a normal methylmalonic acid level.

That's how you tell them apart biochemically.

Let's quickly list the causes.

Folate deficiency is usually due to poor diet, like in alcoholism or high demand, like in pregnancy.

Right, it's pretty easy to become folate deficient.

But B12 is harder to lose.

We have huge stores in our liver.

We have years worth of stores.

So B12 deficiency is almost always an absorption problem, not a dietary one, unless you're a very strict long -term vegan.

And what do you need for absorption?

You need a protein called intrinsic factor, which is made by the parietal cells in the stomach.

Intrinsic factor binds to B12 and allows it to be absorbed way down in the terminal ilium.

So things that mess that up.

Pernicious anemia is the classic cause.

It's an autoimmune attack that destroys those parietal cells.

No parietal cells means no intrinsic factor, which means no B12 absorption.

And also things like a gastrectomy or Crohn's disease that damages the terminal ilium.

Or the most exotic cause, the fish tapeworm, doethilobothrium latum.

It eats your B12.

It sits in your gut and eats your B12 before you can absorb it.

Okay, finally, section six, polycythemia.

The text saves this for last, but we need to give it its due.

This is the opposite problem.

Too many red blood cells.

A high hematocrit.

The blood is too thick.

How do we classify this?

The book uses the EPO level as the guide.

Right, you have to ask, is the EPO level high or is it low?

That tells you everything.

Okay, scenario A.

The bone marrow has gone rogue.

It's making red blood cells like crazy without any signal from the kidney.

This is polycythemia vera.

It's a primary problem in the marrow.

And since the marrow is acting independently, the feedback loop to the kidney turns the EPO signal off.

So high red blood cells, but low EPO.

This is a myeloproliferative disorder, a type of blood cancer.

It's usually caused by a mutation in a gene called JA2.

Okay, scenario B.

The EPO is the one driving the bus.

This is secondary polycythemia.

The EPO level is high, and that's what's telling the marrow to overproduce.

And this can be appropriate.

Meaning the body actually needs more oxygen.

You're living at high altitude.

You have chronic lung disease.

You're a heavy smoker.

The kidney senses hypoxia and correctly releases EPO.

Or it can be inappropriate.

Right.

This is usually perineoplastic.

A tumor, classically a renal cell carcinoma, is secreting EPO ectopically.

It's making EPO when it shouldn't be.

In both of these cases, you have high red blood cells and high EPO.

And lastly, what is relative polycythemia?

That's a fake out.

The red blood cell mass is actually normal.

The problem is that the plasma volume is low because the patient is dehydrated, maybe from severe burns or diarrhea.

The concentration of red cells looks high, but it's just hemoconcentration.

That makes sense.

We have covered a massive amount of ground.

From the cytoskeleton of the spherocyte to the JHA2 mutation of polycythemia vera.

It's a huge chapter.

It is.

Before we go, I want to leave the listener the final thought, something the text touches on regarding evolution.

We spent a lot of time talking about sickle cell and thalassemia.

These are objectively terrible, devastating diseases.

So why are they still around?

Why didn't natural selection just weed them out?

It's a fascinating question.

And the answer is malaria.

The parasite.

The parasite.

It turns out that having the trait, being a carrier with just one copy of the bad gene for either sickle cell or thalassemia confers significant protection against severe malaria.

How?

The plasmodium falciparum parasite can't reproduce as effectively in those abnormal red blood cells.

So in areas of the world where malaria is endemic, like parts of Africa and the Mediterranean, having that bad gene was actually a powerful survival advantage.

It protected you from a deadly infection.

So it's a biological trade -off.

A perfect example of a biological trade -off.

The disease persists in the population because in its carrier state, it once saved your ancestors from something even worse.

It's a powerful reminder that pathology is often just physiology pushed to an extreme or a compromise that might have outlived its original context.

Absolutely.

Thank you for diving deep with us today.

We hope this has helped visualize the invisible world of the red blood cell for you.

Keep questioning the mechanism.

That's always the key.

This has been the Last Minute Lecture Team.

Thanks for listening.